These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26616039)

  • 1. Ten-year performance of Influenzanet: ILI time series, risks, vaccine effects, and care-seeking behaviour.
    van Noort SP; Codeço CT; Koppeschaar CE; van Ranst M; Paolotti D; Gomes MG
    Epidemics; 2015 Dec; 13():28-36. PubMed ID: 26616039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in Europe.
    Koppeschaar CE; Colizza V; Guerrisi C; Turbelin C; Duggan J; Edmunds WJ; Kjelsø C; Mexia R; Moreno Y; Meloni S; Paolotti D; Perrotta D; van Straten E; Franco AO
    JMIR Public Health Surveill; 2017 Sep; 3(3):e66. PubMed ID: 28928112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza syndromic surveillance and vaccine efficacy in the UK Armed Forces, 2017-2018.
    Dermont MA; Elmer T
    J R Army Med Corps; 2019 Dec; 165(6):395-399. PubMed ID: 30842221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic.
    Carrat F; Flahault A; Boussard E; Farran N; Dangoumau L; Valleron AJ
    J Epidemiol Community Health; 1998 Apr; 52 Suppl 1():32S-38S. PubMed ID: 9764269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutracking weekly online community survey of influenza-like illness annual report 2011 and 2012.
    Carlson SJ; Dalton CB; Butler MT; Fejsa J; Elvidge E; Durrheim DN
    Commun Dis Intell Q Rep; 2013 Dec; 37(4):E398-406. PubMed ID: 24882237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsupervised extraction of epidemic syndromes from participatory influenza surveillance self-reported symptoms.
    Kalimeri K; Delfino M; Cattuto C; Perrotta D; Colizza V; Guerrisi C; Turbelin C; Duggan J; Edmunds J; Obi C; Pebody R; Franco AO; Moreno Y; Meloni S; Koppeschaar C; Kjelsø C; Mexia R; Paolotti D
    PLoS Comput Biol; 2019 Apr; 15(4):e1006173. PubMed ID: 30958817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years.
    Nichol KL; D'Heilly SJ; Greenberg ME; Ehlinger E
    Clin Infect Dis; 2009 Feb; 48(3):292-8. PubMed ID: 19115970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participatory Syndromic Surveillance of Influenza in Europe.
    Guerrisi C; Turbelin C; Blanchon T; Hanslik T; Bonmarin I; Levy-Bruhl D; Perrotta D; Paolotti D; Smallenburg R; Koppeschaar C; Franco AO; Mexia R; Edmunds WJ; Sile B; Pebody R; van Straten E; Meloni S; Moreno Y; Duggan J; Kjelsø C; Colizza V
    J Infect Dis; 2016 Dec; 214(suppl_4):S386-S392. PubMed ID: 28830105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination among college and university students: impact on influenzalike illness, health care use, and impaired school performance.
    Nichol KL; D'Heilly S; Ehlinger EP
    Arch Pediatr Adolesc Med; 2008 Dec; 162(12):1113-8. PubMed ID: 19047537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing syndromic surveillance data for estimating levels of influenza circulation.
    Patterson-Lomba O; Van Noort S; Cowling BJ; Wallinga J; Gomes MG; Lipsitch M; Goldstein E
    Am J Epidemiol; 2014 Jun; 179(11):1394-401. PubMed ID: 24748609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine effectiveness and confounding factors among young children.
    Fujieda M; Maeda A; Kondo K; Fukushima W; Ohfuji S; Kaji M; Hirota Y
    Vaccine; 2008 Nov; 26(50):6481-5. PubMed ID: 18573294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flutracking weekly online community survey of influenza-like illness: 2013 and 2014.
    Dalton CB; Carlson SJ; McCallum L; Butler MT; Fejsa J; Elvidge E; Durrheim DN
    Commun Dis Intell Q Rep; 2015 Sep; 39(3):E361-8. PubMed ID: 26620350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long time trends in influenza-like illness and associated determinants in The Netherlands.
    Dijkstra F; Donker GA; Wilbrink B; Van Gageldonk-Lafeber AB; Van Der Sande MA
    Epidemiol Infect; 2009 Apr; 137(4):473-9. PubMed ID: 18789176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of follow-up participation in the Internet-based European influenza surveillance platform Influenzanet.
    Bajardi P; Vespignani A; Funk S; Eames KT; Edmunds WJ; Turbelin C; Debin M; Colizza V; Smallenburg R; Koppeschaar CE; Franco AO; Faustino V; Carnahan A; Rehn M; Paolotti D
    J Med Internet Res; 2014 Mar; 16(3):e78. PubMed ID: 24613818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The representativeness of a European multi-center network for influenza-like-illness participatory surveillance.
    Cantarelli P; Debin M; Turbelin C; Poletto C; Blanchon T; Falchi A; Hanslik T; Bonmarin I; Levy-Bruhl D; Micheletti A; Paolotti D; Vespignani A; Edmunds J; Eames K; Smallenburg R; Koppeschaar C; Franco AO; Faustino V; Carnahan A; Rehn M; Colizza V
    BMC Public Health; 2014 Sep; 14():984. PubMed ID: 25240865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.